0HCV Stock Overview
UBS ETF SICAV - MSCI Hong Kong UCITS ETF is an exchange traded fund launched by UBS Fund Management (Luxembourg) S.A.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
UBS ETF SICAV - MSCI Hong Kong UCITS ETF Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$13.66 |
52 Week High | US$13.66 |
52 Week Low | US$11.77 |
Beta | 0 |
1 Month Change | n/a |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | -37.48% |
5 Year Change | -35.58% |
Change since IPO | -25.74% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
0HCV | GB Capital Markets | GB Market | |
---|---|---|---|
7D | 16.0% | 2.3% | 0.7% |
1Y | n/a | 9.0% | 3.0% |
Return vs Industry: Insufficient data to determine how 0HCV performed against the UK Capital Markets industry.
Return vs Market: Insufficient data to determine how 0HCV performed against the UK Market.
Price Volatility
0HCV volatility | |
---|---|
0HCV Average Weekly Movement | n/a |
Capital Markets Industry Average Movement | 4.5% |
Market Average Movement | 4.8% |
10% most volatile stocks in GB Market | 11.4% |
10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: 0HCV has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 0HCV's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2015 | n/a | n/a | fundgate.ubs.com/fioverview.do?instid=100006374&rid=20&cty=LU&qsearch=Hong+Kong+Ucits+&lang=en |
UBS ETF SICAV - MSCI Hong Kong UCITS ETF is an exchange traded fund launched by UBS Fund Management (Luxembourg) S.A. It is co-managed by UBS Asset Management and UBS Asset Management (UK) Limited. The fund invests in the public equity markets of Hong Kong.
UBS ETF SICAV - MSCI Hong Kong UCITS ETF Fundamentals Summary
0HCV fundamental statistics | |
---|---|
Market cap | n/a |
Earnings (TTM) | US$0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs 0HCV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
0HCV income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$0 |
Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did 0HCV perform over the long term?
See historical performance and comparison